• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    VP of Food and Health Sciences Jones Gregory Alan was granted 3,411 shares, increasing direct ownership by 75% to 7,980 units (SEC Form 4)

    5/16/25 4:30:47 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Jones Gregory Alan

    (Last) (First) (Middle)
    2381 ROSEGATE

    (Street)
    ROSEVILLE MN 55113

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HAWKINS INC [ HWKN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    VP of Food and Health Sciences
    3. Date of Earliest Transaction (Month/Day/Year)
    05/14/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/14/2025 A 3,411 A $0 7,980 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    /s/ Joshua L. Colburn, Attorney-in-Fact 05/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HWKN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    7/24/2025Mkt Perform
    Raymond James
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hawkins, Inc. to Participate in the Seaport Research Partners' 14th Annual Summer Investor Conference

    ROSEVILLE, Minn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that Patrick Hawkins, Chief Executive Officer, and Jeff Oldenkamp, Chief Financial Officer, will participate in Seaport Research Partners' 14th Annual Summer Investor Conference. The conference will be held virtually August 19 to August 20, 2025 and is hosted by Seaport Research Partners. It is expected to include over 500 institutional buy-side investors and feature one-on-one and small group meetings. Hawkins will participate on August 20, 2025. For more information about the conference or to schedule a meeting with Hawkins manage

    8/6/25 9:36:14 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A

    7/30/25 4:10:59 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Increases its Quarterly Cash Dividend by 6% to $0.19 Per Share

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i

    7/30/25 4:05:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Faulconbridge James A bought $161,899 worth of shares (1,800 units at $89.94), increasing direct ownership by 4% to 47,817 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/14/24 4:09:43 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Faulconbridge James A bought $351,036 worth of shares (4,000 units at $87.76), increasing direct ownership by 10% to 46,017 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/12/24 6:02:44 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Faulconbridge James A bought $288,907 worth of shares (3,300 units at $87.55), increasing direct ownership by 9% to 42,017 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/10/24 4:27:25 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on Hawkins

    Raymond James initiated coverage of Hawkins with a rating of Mkt Perform

    7/24/25 7:27:35 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins upgraded by BWS Financial with a new price target

    BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $160.00

    4/14/25 9:28:56 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    CJS Securities initiated coverage on Hawkins with a new price target

    CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00

    4/1/25 9:13:14 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    SEC Filings

    View All

    Hawkins Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HAWKINS INC (0000046250) (Filer)

    8/8/25 7:47:05 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - HAWKINS INC (0000046250) (Filer)

    8/1/25 8:17:38 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 10-Q filed by Hawkins Inc.

    10-Q - HAWKINS INC (0000046250) (Filer)

    7/30/25 4:16:10 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schumacher Mary J. was granted 628 shares, increasing direct ownership by 2% to 26,177 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:20:37 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Spethmann Jeffrey E was granted 628 shares, increasing direct ownership by 12% to 5,911 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:20:15 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Tang Yi was granted 628 shares, increasing direct ownership by 9% to 7,891 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:19:48 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Financials

    Live finance-specific insights

    View All

    Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A

    7/30/25 4:10:59 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Increases its Quarterly Cash Dividend by 6% to $0.19 Per Share

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i

    7/30/25 4:05:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    HAWKINS, INC. TO RELEASE FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ON JULY 30, 2025

    ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) --  Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se

    7/16/25 8:45:00 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Leadership Updates

    Live Leadership Updates

    View All

    THE TRŪ® SHRIMP COMPANIES APPOINTS HAWKINS AS EXCLUSIVE U.S. DISTRIBUTOR FOR TRŪ® CHITOSAN

    BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph

    8/16/23 9:00:00 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc.  Announces Retirement of Director John McKeon

    Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020.  Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope.  With his support and guidance, we have built a solid company that is poised for cont

    12/18/20 4:10:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hawkins Inc.

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    10/31/24 11:54:59 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    2/13/24 5:06:13 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    2/9/24 9:59:13 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary